General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas-Reference-Cited by-同舟云学术

General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas

Published:1990-04-15 Issue:4 Volume:45 Page:644-649
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Van Den Brule Adriaan J. C.,Snijders Peter J. F.,Gordijn Roel L. J.,Bleker Otto P.,Meijer Chris J. L. M.,Walboomers Jan M. M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. PROGRESSIVE POTENTIAL OF MILD CERVICAL ATYPIA: PROSPECTIVE CYTOLOGICAL, COLPOSCOPIC, AND VIROLOGICAL STUDY

2. Sequence duplication and internal deletion in the integrated human papillomavirus type 16 genome cloned from a cervical carcinoma

3. The polymerase chain reaction, a review of the practical limitations for human immunodeficiency virus diagnosis

4. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome

5. Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management;Journal of Medical Virology;2024-06

2. Harald zur Hausen (1936 to 2023): Discoverer of human papillomavirus infection as the main cause of cervical cancer;Proceedings of the National Academy of Sciences;2024-03-04

3. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens;Journal of Medical Microbiology;2020-07-01

4. Human papillomavirus as a factor in the development of cervical cancer;Yakut Medical Journal;2020

5. Primary Screening by Human Papillomavirus Testing: Development, Implementation, and Perspectives;Human Papillomavirus;2020